Evidence-Based Complementary and Alternative Medicine

TCM Zheng Classification and Clinical Trials


Publishing date
31 May 2013
Status
Published
Submission deadline
11 Jan 2013

Lead Editor

1Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China

2Centre for Complementary Medicine Research (CompleMED), University of Western Sydney, Penrith, Australia

3Evidence Based Medicine Center, Beijing University of Chinese Medicine, Hepingli, Beijing 100029, China

4School of Chinese Medicine, Hong Kong Baptist University, Kowloon, Hong Kong

5Queen Elizabeth Hospital, Kowloon, Hong Kong


TCM Zheng Classification and Clinical Trials

Description

The traditional Chinese medicine (TCM) Zheng (or syndrome) is an outcome of analysis on TCM information by TCM practitioner. Zheng classification is a traditional diagnostic method to categorize the patients based on their different conditions. Currently combination of Zheng classification and biomedical diagnosis becomes a common model in diagnostics in TCM clinical practice. Clinical treatments of a patient rely on the successful differentiation of a specific TCM Zheng.

Recently a great progress has been made in the clinical studies focusing on the exploration of effect of TCM interventions in the patients with clarified TCM Zheng in some certain diseases. The clinical studies with TCM Zheng classification will lead to personalized therapeutic strategies. We believe it will be a hot topic in the coming years for the basic and clinical research.

We invite investigators to contribute original research articles as well as review articles that will apply Zheng classification to basic research, clinical practice, and clinical research to improve the efficacy of TCM interventions, and further lead to personalized treatment. The information obtained from these studies shall be clearly evidence-based. We are particularly interested in articles describing the clinical trials with TCM Zheng classification, Zheng classification methodology from clinical data, systematic reviews on clinical studies using Zheng classification, clinical practice guideline or expert consensus focused on TCM Zheng in certain of diseases, reviews on clinical practice guidelines or expert consensus related to Zheng classification, and the clinical pharmacological evaluation on TCM interventions using the omics methods as well as bioinformatics. Potential topics include, but are not limited to:

  • Randomized clinical trials designed with Zheng classification
  • Zheng classification-based systematic reviews on clinical trials
  • Zheng classification-based clinical practice guideline or expert consensus
  • Clinical trial protocols based on TCM Zheng classification
  • Clinical pharmacological studies based on Zheng classification
  • Reviews on clinical practice guidelines based on Zheng classification
  • Data mining on clinical data for ZHENG classification
  • Recent advances in ZHENG classification-based clinical trials

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/ecam/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/ecam/tcm/ according to the following timetable:

Evidence-Based Complementary and Alternative Medicine
 Journal metrics
See full report
Acceptance rate7%
Submission to final decision145 days
Acceptance to publication29 days
CiteScore3.500
Journal Citation Indicator-
Impact Factor-
 Submit Check your manuscript for errors before submitting

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.